F. Hoffmann-La Roche had ten patents in internet of things during Q1 2024.The patents filed by F. Hoffmann-La Roche Ltd in Q1 2024 focus on innovative medical systems and devices. These include a body-wearable medical device with a disposable container for storing food or drugs, a traceable medical vial with electronic tracking components, and a system for determining the location of an individual using beacons in a confined space. GlobalData’s report on F. Hoffmann-La Roche gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
F. Hoffmann-La Roche grant share with internet of things as a theme is 40% in Q1 2024. Grant share is based on the ratio of number of grants to total number of patents.
Recent Patents
Application: Medical device system, and disposable container (Patent ID: US20240050651A1)
The patent filed by F. Hoffmann-La Roche Ltd. describes a medical system that includes a body-wearable medical device, such as an insulin pump or continuous glucose monitor, along with a disposable container for storing foodstuff or drugs. The disposable container has a tamper-evident closure and an opening for accessing the reservoir, which can be fastened to the body-wearable medical device using a mechanical, non-adhesive fastener like a bracket. The fastener ensures secure attachment of the container to the device, allowing for convenient and safe storage of necessary substances.
The system also includes various claims related to the design and functionality of the medical system, such as the use of specific fasteners like hook-and-loop or latch fasteners, the volume of the reservoir, and the presence of a venting closure. Additionally, the patent covers the design of the disposable container itself, emphasizing the tamper-evident closure, reservoir for storing substances, and the fastening mechanism for attaching it to the body-wearable medical device. Overall, the patent aims to provide a practical and efficient solution for storing and accessing necessary substances in a medical setting, particularly for individuals managing conditions like diabetes.
To know more about GlobalData’s detailed insights on F. Hoffmann-La Roche, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.
